AI assistant
AMICUS THERAPEUTICS, INC. — Director's Dealing 2014
Dec 24, 2014
31523_dirs_2014-12-24_57f69766-fe2d-4162-acf8-3191e2222c67.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2014-12-22
Reporting Person: Do Hung (Sr Vice President Discovery)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-12-22 | Common stock | D | 41441 | $8.43 | Disposed | 911722 | Direct |
Footnotes
F1: The sales of shares of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 5, 2014.
F2: This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.84 to $8.74. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.